Neeltje A. Kootstra
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 195 publications
Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells.
Journal: Journal of virology
Published: July 29, 2026
Capsid-Targeting Biologic Achieves Broad HIV-1 Neutralization with a High Barrier to Resistance.
Journal: International journal of molecular sciences
Published: May 26, 2026
Refining inflammatory profiles linked to cardiometabolic outcomes in people with HIV using recursive feature addition modelling.
Journal: Clinical and translational medicine
Published: May 09, 2026
Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency.
Journal: PloS one
Published: April 23, 2026
Blocking Host Factors IAP and DDX3 Activates HIV-1 Transcription and Increases Apoptosis Sensitivity of HIV-1 Infected Cells.
Journal: Pathogens (Basel, Switzerland)
Published: February 16, 2026
Transcriptomic Signatures of Immune Suppression and Cellular Dysfunction Distinguish Latent from Transcriptionally Active HIV-1 Infection in Dendritic Cells.
Journal: International journal of molecular sciences
Published: December 05, 2025
Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approach.
Journal: PLoS computational biology
Published: November 24, 2025
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.
Journal: The Journal of infection
Published: November 20, 2025
Association of leukocyte count with death in people with HIV: A longitudinal study over 24 years.
Journal: PloS one
Published: September 14, 2025
Anti-capsid nanobodies function as HIV-1 capsid inhibitors by intracellular capsid degradation.
Journal: Communications biology
Published: September 11, 2025
Last Updated: 09/26/2026